Clinical and therapeutic aspects of congenital and acquired long QT syndrome (Q33147293)

22 July 2017

1 reference

title

Clinical and therapeutic aspects of congenital and acquired long QT syndrome (English)

1 reference

22 July 2017

0 references

1 reference

Ijaz A Khan

1 reference

22 July 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

American Journal of Medicine

22 July 2017

published in

1 reference

22 July 2017

volume

112

1 reference

22 July 2017

1 reference

22 July 2017

page(s)

58-66

1 reference

QT interval change with age in an overtly healthy older population.

22 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

The long QT syndrome. Prospective longitudinal study of 328 families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Molecular biology and the prolonged QT syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Molecular biology of K(+) channels and their role in cardiac arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Molecular biology of sodium channels and their role in cardiac arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Calcium currents and arrhythmias: insights from molecular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Mutations in the hminK gene cause long QT syndrome and suppress lKs function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Molecular genetics of inherited long QT syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

A structural basis for drug-induced long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Electrophysiological remodeling in hypertrophy and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Ventricular arrhythmias and hypokalaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Torsade de Pointes Induced by Hypocalcemia in a Postoperative Patient with Thyrotoxicosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Relation between QT and RR intervals in patients with bradyarrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Cocaine-induced torsades de pointes in idiopathic long Q-T syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Cardiac manifestations of acute carbamate and organophosphate poisoning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Torsade de pointes as a complication of subarachnoid hemorrhage: a critical reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Cardiac effects of starvation and semistarvation diets: safety and mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet. Observations in 17 patients and the role of the prolonged QT interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Long QTc and Torsades de Pointes in Human Immunodeficiency Virus Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Torsades de pointes: a case with multiple variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Value of Holter Monitoring in Patients with the Long QT Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Electrical alternation of the T-wave: Clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

ECG T-Wave Patterns in Genetically Distinct Forms of the Hereditary Long QT Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Long QT syndrome presenting as a seizure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Increased propensity of women to develop torsades de pointes during complete heart block

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Mechanisms in adrenergic dependent onset of torsades de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Mode of onset of torsade de pointes in congenital long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Idiopathic long QT syndrome: progress and questions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Diagnostic criteria for the long QT syndrome. An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Rate adaptation of QT intervals during and after exercise in children with congenital long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Torsades de pointes therapy with phenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Treatment of torsade de pointes with magnesium sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

"Torsades de pointes" and atrioventricular block

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Effects of pacing on triggered activity induced by early afterdepolarizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Polymorphous ventricular tachycardia: clinical features and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Prevention of ventricular arrhythmias in the congenital long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Cardiac pacing in the long QT syndrome: review of available data and practical recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Permanent cardiac pacing in patients with the long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Rate smoothing with cardiac pacing for preventing torsade de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

The automatic implantable cardioverter-defibrillator in young patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Pharmacological targeting of long QT mutant sodium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Sodium Channel Block With Mexiletine Is Effective in Reducing Dispersion of Repolarization and Preventing Torsade de Pointes in LQT2 and LQT3 Models of the Long-QT Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Suppression of Erythromycin‐induced Early Afterdepolarizations and Torsade de Pointes Ventricular Tachycardia by Mexiletine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Early Afterdepolarization Abolished by Potassium Channel Opener in a Patient with Idiopathic Long QT Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

Nicorandil, a potent cardioprotective agent, reduces QT dispersion during coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

The long QT syndrome in children. An international study of 287 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901011-7

10.1016/S0002-9343(01)01011-7

7 January 2021

Identifiers

DOI

1 reference

22 July 2017

1 reference